| Masthead |
|
|
|
|
|
|
|
|
|
| Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes |
|
|
|
|
|
|
|
|
|
| Multiplede novo MPZ (P0) point mutations in a sporadic Dejerine-Sottas case |
|
|
|
|
|
|
|
|
|
| The cystic fibrosis ΔF508 gene mutation and cancer |
|
|
|
|
|
|
|
|
|
| Molecular heterogeneity of classical and duarte galactosemia: Mutation analysis by denaturing gradient gel electrophoresis |
|
|
|
|
|
|
|
|
|
| Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient |
|
|
|
|
|
|
|
|
|
| Glycogenosis type II: A juvenile-specific mutation with an unusual splicing pattern and a shared mutation in African Americans |
|
|
|
|
|
|
✓ |
|
African Americans |
| Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations |
|
|
|
|
✓ |
|
|
|
European populations |
| Familial ligand-defective apolipoprotein B-100: Simultaneous detection of the ARG3500→GLN and ARG3531→CYS mutations in a French population |
|
|
|
|
|
|
|
|
|
| Identification of a new mutation of the myosin VII head region in Usher syndrome type 1 |
|
|
|
|
|
|
|
|
|
| Hereditary coproporphyria: Exon screening by heteroduplex analysis detects three novel mutations in the coproporphyrinogen oxidase gene |
|
|
|
|
|
|
|
|
|
| Analysis of 22 cystic fibrosis mutations in 62 patients from the Flanders, Belgium, reveals a high prevalence of Nordic mutation 394delTT |
|
|
|
|
|
|
✓ |
|
Nordic |
| Adult vitelliform macular dystrophy is frequently associated with mutations in the peripherin/RDS gene |
|
|
|
|
|
|
|
|
|
| Molecular basis of dystrophic epidermolysis bullosa: Mutations in the type VII collagen gene (COL7A1) |
|
|
|
|
|
|
|
|
|
| Hunter disease in a girl caused by R468Q mutation in the iduronate-2-sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele |
|
|
|
|
|
|
|
|
|
| Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: Study of 19 heterozygous and 2 homozygous patients |
|
|
|
|
|
|
|
|
|
| Cystic fibrosis mutation frequencies in upstate New York |
|
|
|
|
|
|
|
|
|
| Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: Characterization of 14 C×32 mutations in 35 families |
|
|
|
|
|
|
|
|
|
| Analysis of (CAG)n size heterogeneity in somatic and sperm cell DNA from intermediate and expanded Huntington disease gene carriers |
|
|
|
|
|
|
|
|
|
| Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A) |
|
|
|
|
|
|
|
|
|
| Two extremes of the clinical spectrum of glycogen storage disease type II in one family: A matter of genotype |
|
|
|
|
|
|
|
|
|
| Mutations inmut methylmalonic acidemia: Clinical and enzymatic correlations |
|
|
|
|
|
|
|
|
|
| A nonsense mutation due to a single base insertion in the 3′-coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa |
|
|
|
|
|
|
|
|
|
| Mutations of the androgen receptor gene in patients with complete androgen insensitivity |
|
|
|
|
|
|
|
|
|
| Novel mutation of the myelin P0 gene in a CMT1B family |
|
|
|
|
|
|
|
|
|
| Three novel mutations in the coproporphyrinogen oxidase gene |
|
|
|
|
|
|
|
|
|
| Molecular analysis of theAPC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis |
|
|
|
|
|
|
✓ |
|
Dutch |
| Two novel mutations (K384E and L539S) in the C-terminal moiety of the cystathionine β-synthase protein in two French pyridoxine-responsive homocystinuria patients |
|
|
|
|
|
|
✓ |
|
French |
| Mutations in purine nucleoside phosphorylase deficiency |
|
|
|
|
|
|
|
|
|
| Three germline mutations in theTP53 gene |
|
|
|
|
|
|
|
|
|
| Mutational analysis of the hMLH1 gene using an automated two-dimensional DNA typing system |
|
|
|
|
|
|
|
|
|
| E380D: A novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
|
|
|
|
|
|
|
|
|
| Identification of two mutations (S50Y and 4173delC) in theCFTR gene from patients with congenital bilateral absence of vas deferens (CBAVD) |
|
|
|
|
|
|
|
|
|
| Startle disease in an Italian family by mutation (K276E): The α-subunit of the inhibiting glycine receptor |
|
|
|
|
|
|
✓ |
|
Italian |
| Novel mutations and polymorphisms in the human dystrophin gene detected by double-strand conformation analysis |
|
|
|
|
|
|
|
|
|
| Mutations of theRET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease |
|
|
|
|
|
|
|
|
|
| Metachromatic leukodystrophy: Identification of the first deletion in exon 1 and nine novel point mutations in the arylsulfatase A gene |
|
|
|
|
|
|
|
|
|
| NovelHEXA mutation in a Bedouin Tay-Sachs patient associated with exon skipping and reduced transcript level |
|
|
|
|
|
|
|
|
|
| Quantitative allele-specific PCR: Demonstration of age-associated accumulation in human tissues of the A→G mutation at nucleotide 3243 in mitochondrial DNA |
|
|
|
|
|
|
|
|
|
| Complex trinucleotide repeat polymorphism in the HOX B6 gene |
|
|
|
|
|
|
|
|
|
| G→T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP |
|
|
|
|
|
|
|
|
|
| Detection of mutations in multi-exon genes: Comparison of conformation sensitive gel electrophoresis and sequencing strategies with respect to cost and time for finding mutations |
|
|
|
|
|
|
|
|
|
| Novel G16S (GGC-AGC) mutation in theSOD-1 gene in a patient with apparently sporadic young-onset amyotrophic lateral sclerosis |
|
|
|
|
|
|
|
|
|
| Three novel fibrillin mutations in exons 25 and 27: Classic versus neonatal Marfan syndrome |
|
|
|
|
|
|
|
|
|
| Novel nonsense mutation (W302X) in the steroid 21-hydroxylase gene of a Finnish patient with the salt-wasting form of congenital adrenal hyperplasia |
|
|
|
|
|
|
✓ |
|
Finnish patient |
| New evidence for a mutation hotspot in exon 37 of the
<i>NF1</i>
gene |
|
|
|
|
|
|
|
|
|
| Mutations inSRY andSOX9: Testis-determining genes |
|
|
|
|
|
|
|
|
|
| Norrie disease gene mutation in a large Costa Rican kindred with a novel phenotype including venous insufficiency |
|
|
|
|
|
|
|
|
|
| Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X‐linked agammaglobulinemia |
|
|
|
|
|
|
|
|
|
| Analysis of the myoglobin gene in heart disease |
|
|
|
|
|
|
|
|
|
| Two mutations in the same low-density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Similar mutant frequencies observed between pairs of monozygotic twins |
|
|
|
|
|
|
|
|
|
| Recurrent COL3A1 mutation results in EDS IV or familial aneurysms |
|
|
|
|
|
|
|
|
|
| Mutations in the adrenoleukodystrophy gene |
|
|
|
|
|
|
|
|
|
| Screening forESR mutations in breast and ovarian cancer patients |
|
|
|
|
|
|
|
|
|
| SSCP analysis: A blind sensitivity trial |
|
|
|
|
|
|
|
|
|
| Homozygosity for the common Ashkenazi Jewish Tay-Sachs +1 IVS-12 splice-junction mutation: First report |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jewish |
| Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Cys 618 Arg mutation in the RET proto-oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting |
|
|
|
|
|
|
|
|
|
| Three novel mutations of thePKD1 gene in Italian families with autosomal dominant polycystic kidney disease |
|
|
|
|
|
|
|
|
|
| Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1) |
|
|
|
|
|
|
|
|
|
| Novel mutations of theP gene in type II oculocutaneous albinism (OCA2) |
|
|
|
|
|
|
|
|
|
| E280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles |
|
|
|
|
|
|
|
|
|
| Constitutive APC exon 14 skipping in early-onset familial adenomatous polyposis reveals a dramatic quantitative distortion ofAPC gene-specific isoforms |
|
|
|
|
|
|
|
|
|
| The molecular basis of X-linked deafness type 3 (DFN3) in two sporadic cases: Identification of a somatic mosaicism for aPOU3F4 missense mutation |
|
|
|
|
|
|
|
|
|
| Sporadic heteroplasmic single 5.5 Kb mitochondrial DNA deletion associated with cerebellar ataxia, hypogonadotropic hypogonadism, choroidal dystrophy, and mitochondrial respiratory chain complex I def |
|
|
|
|
|
|
|
|
|
| Two novel frameshift deletions (1924del7, 2055del9→A) in the CFTR gene in Mexican cystic fibrosis patients |
|
|
|
|
|
|
|
|
|
| Hereditary nonpolyposis colorectal cancer (HNPCC): Eight novel germline mutations in hMSH2 or hMLH1 genes |
|
|
|
|
|
|
|
|
|
| G6PD Sumaré: A novel mutation in the G6PD gene (1292 T→G) associated with chronic nonspherocytic anemia |
|
|
|
|
|
|
|
|
|
| Six novel mutations in the neurofibromatosis type 1 (NF1) gene |
|
|
|
|
|
|
|
|
|
| Human APRT deficiency: Indication for multiple origins of the most common Caucasian mutation and detection of a novel type of mutation involving intrastrand-templated repair |
✓ |
|
|
|
|
|
|
|
|
| Molecular genetics of Krabbe disease (globoid cell leukodystrophy): Diagnostic and clinical implications |
|
|
|
|
|
|
|
|
|
| Evidence for founder effect of the glu104asp substitution and identification of new mutations in triosephosphate isomerase deficiency |
|
|
|
|
|
|
|
|
|
| Tay-Sachs disease andHEXA mutations among Moroccan Jews |
|
|
|
|
|
|
✓ |
|
Moroccan Jews |
| Confirmation of homozygosity for a single nucleotide substitution mutation in a Cockayne syndrome patient using monoallelic mutation analysis in somatic cell hybrids |
|
|
|
|
|
|
|
|
|
| Imprinting mutations on human chromosome 15 |
|
|
|
|
|
|
|
|
|
| Glucocerebrosidase genotype of Gaucher patients in The Netherlands: Limitations in prognostic value |
|
|
|
|
|
|
|
|
|
| Two novel (1334delC and 1363G to A, G455R) mutations in exon 12 of the β-hexosaminidase α-chain gene in two Portuguese patients |
|
|
|
|
|
|
✓ |
|
Portuguese patients |
| Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS gene |
|
|
|
|
|
|
|
|
|
| APC mutations in familial adenomatous polyposis families in the Northwest of England |
|
|
|
|
|
|
|
|
|
| Fibrillin-1 mutations in Marfan syndrome and other type-1 fibrillinopathies |
|
|
|
|
|
|
|
|
|
| Molecular basis of heat labile hexosaminidase B among Jews and Arabs |
|
|
|
|
|
|
|
|
|
| Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency |
|
|
|
|
|
|
|
|
|
| Two mutatedHEXA alleles in a Druze patient with late-infantile Tay-Sachs disease |
|
|
|
|
|
|
|
|
|
| Familial lipoprotein lipase (LPL) deficiency: A catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy |
|
|
|
|
|
|
|
|
|
| Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas |
|
|
|
|
|
|
|
|
|
| The repeat expansion detection method in the analysis of diseases with CAG/CTG repeat expansion: Usefulness and limitations |
|
|
|
|
|
|
|
|
|
| Method for in situ investigation of mitochondrial DNA deletions |
|
|
|
|
|
|
|
|
|
| An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia |
|
|
|
|
|
|
|
|
|
| Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects |
|
|
|
|
|
|
|
|
|
| Simultaneous genotyping for all three known structural mutations in the human mannose-binding lectin gene |
|
|
|
|
|
|
|
|
|
| Mutation analysis of the connexin 32 (Cx32) gene in charcot-marie-tooth neuropathy type 1: Identification of five new mutations |
|
|
|
|
|
|
|
|
|
| Two new mutations in exon 3 of theNDP gene: S73X and S101F associated with severe and less severe ocular phenotype, respectively |
|
|
|
|
|
|
|
|
|
| A novel splice site mutation (156 + 1G→A) in theTSC2 gene |
|
|
|
|
|
|
|
|
|
| Phenylketonuria in Spanish Gypsies: Prevalence of the IVS10nt546 mutation on haplotype 34 |
|
|
|
|
|
|
✓ |
|
Spanish Gypsies |
| A novel missense point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patient with familal motor neuron disease |
|
|
|
|
|
|
|
|
|
| Novel missense mutation in the coagulation factor IX catalytic domain associated with moderate disease |
|
|
|
|
|
|
|
|
|
| Transthyretin ILE20, a new variant associated with late-onset cardiac amyloidosis |
|
|
|
|
|
|
|
|
|
| Phenylketonuria splice mutation (EXON6nt-96Ag) masquerading as missense mutation (Y204C) |
|
|
|
|
|
|
|
|
|
| New splicing mutation in exon 5–6 of the p53-tumor suppressor gene in a malignant schwannoma |
|
|
|
|
|
|
|
|
|
| CTG trinucleotide repeat lengths in myotonic dystrophy alleles of patients with senile cataracts |
|
|
|
|
|
|
|
|
|
| Molecular basis of choroideremia (CHM): Mutations involving the rab escort protein-1 (REP-1) gene |
|
|
|
|
|
|
|
|
|
| Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis |
|
|
|
|
|
|
|
|
|
| Two new recurrent nucleotide mutations in theCOL1A1 gene in four patients with osteogenesis imperfecta: About one-fifth are recurrent |
|
|
|
|
|
|
|
|
|
| Three novel germline mutations in the adenomatous polyposis coli gene |
|
|
|
|
|
|
|
|
|
| Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene |
|
|
|
|
|
|
|
|
|
| Mutations and DNA diagnoses of classical citrullinemia |
|
|
|
|
|
|
|
|
|
| A high incidence of mutations in exon 6 of the low‐density lipoprotein receptor gene in Greek familial hypercholesterolemia patients, including a novel mutation |
|
|
|
|
|
|
✓ |
|
Greek |
| Identification of three novel frameshift mutations (83delAT, 754insCT, and 435 + 1G to A) of mitochondrial acetoacetyl‐coenzyme A thiolase gene in two Swiss patients with CRM‐negative β‐ketothiolase d |
|
|
|
|
|
|
✓ |
|
Swiss |
| Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: Overview |
|
|
|
|
|
|
|
|
|
| Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vess |
|
|
|
|
|
|
|
|
|
| Identification of a splice site mutation (2789+5 G>A) associated with small amounts of normal CFTRmRNA and mild cystic fibrosis |
|
|
|
|
|
|
|
|
|
| δ-Thalassemic phenotype due to two “novel” δ-globin gene mutations: CD11[GTC → GGC (A8)-HbA2-pylos] and CD 85 [TTT → TCT (F1)-HbA2-etolia] |
|
|
|
|
|
|
|
|
|
| Single-step DGGE-based mutation scanning of thep53 gene: Application to genetic diagnosis of colorectal cancer |
|
|
|
|
|
|
|
|
|
| Serine for glycine substitutions in the C‐terminal third of the α1(I) chain of collagen I in five patients with nonlethal osteogenesis imperfecta |
|
|
|
|
|
|
|
|
|
| Seven novel mutations in carbonic anhydrase II deficiency syndrome identified by SSCP and direct sequencing analysis |
|
|
|
|
|
|
|
|
|
| Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion |
|
|
|
|
|
|
|
|
|
| Deletions spanning the neurofibromatosis type 1 gene: Implications for genotype-phenotype correlations in neurofibromatosis type 1? |
|
|
|
|
|
|
|
|
|
| Scanning method of identify the molecular heterogeneity of δ-globin gene especially in δ-thalassemias: Detection of three novel substitutions in the promoter region of the gene |
|
|
|
|
|
|
|
|
|
| A five‐basepair deletion (7118 delTTTTA) identified within neurofibromatosis NF1 exon 39 |
|
|
|
|
|
|
|
|
|
| Three novel point mutations in the dystrophin gene in DMD patients |
|
|
|
|
|
|
|
|
|
| New nonsense mutation in the breast cancer‐1 gene in a French site‐specific breast cancer family |
|
|
|
|
|
|
|
|
|
| Identification of a novel somatic mutation in the RET proto-oncogene in a patient with sporadic medullary thyroid carcinoma |
|
|
|
|
|
|
|
|
|
| The clinical spectrum of type IV collagen mutations |
|
|
|
|
|
|
|
|
|
| Nine novel L1 CAM mutations in families with X-linked hydrocephalus |
|
|
|
|
|
|
|
|
|
| DNA repair characteristics and mutations in theERCC2 DNA repair and transcription gene in a trichothiodystrophy patient |
|
|
|
|
|
|
|
|
|
| Six novel mutations in the emerin gene causing X‐linked Emery‐Dreifuss muscular dystrophy |
|
|
|
|
|
|
|
|
|
| An efficient and reliable multiplex PCR-SSCP mutation analysis test applied to the human E-cadherin gene |
|
|
|
|
|
|
|
|
|
| Oligonucleotide micro-arrays for identification of unknown mutations: how far from reality? |
|
|
|
|
|
|
|
|
|
| Common founder mutation in the LDL receptor gene causing familial hypercholesterolaemia in the Icelandic population |
|
|
|
|
|
|
|
|
|
| Mucopolysaccharidosis type II: Identification of six novel mutations in Italian patients |
|
|
|
|
|
|
|
|
|
| Mutations associated with hemophilia B in Turkish patients |
|
|
|
|
|
|
|
|
|
| Identification of a one-base germline deletion (codon 888 del C) and an intron splice acceptor site polymorphism in hMSH2 |
|
|
|
|
|
|
|
|
|
| 24 bp deletion and Ala1278 to val mutation of the ATP7B gene in a Sardinian family with Wilson disease |
|
|
|
|
|
|
✓ |
|
Sardinian family |
| Diversity ofATM gene mutations detected in patients with ataxia-telangiectasia |
|
|
|
|
|
|
|
|
|
| Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: Association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmon |
|
|
|
|
|
|
|
|
|
| Molecular basis of HNPCC: Mutations of MMR genes |
|
|
|
|
|
|
|
|
|
| A single Ser259Arg mutation in the gene for lipoprotein lipase causes chylomicronemia in Moroccans of Berber ancestry |
|
|
|
|
|
|
✓ |
|
Moroccans of Berber ancestry |
| Novel point mutations in the dystrophin gene |
|
|
|
|
|
|
|
|
|
| Identification of 31 novel mutations in the N-acetylgalactosamine-6-sulfatase gene reveals excessive allelic heterogeneity among patients with Morquio A syndrome |
|
|
|
|
|
|
|
|
|
| A novel mutation (L174R) in the Ca2+-sensing receptor gene associated with familial hypocalciuric hypercalcemia |
|
|
|
|
|
|
|
|
|
| Lipoamide dehydrogenase deficiency in Ashkenazi Jews: An insertion mutation in the mitochondrial leader sequence |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jews |
| Mutations of the phenylalanine hydroxylase gene in mild hyperphenylalaninemia: A novel mutation in exon 3 |
|
|
|
|
|
|
|
|
|
| Registries of immunodeficiency patients and mutations |
|
|
|
|
|
|
|
|
|
| Mutation screening of all 65 exons of the fibrillin-1 gene in 60 patients with Marfan syndrome: Report of 12 novel mutations |
|
|
|
|
|
|
|
|
|
| Characterization of a deletion mutation involving exons 3–7 of the WASP gene detected in a patient with Wiskott-Aldrich syndrome |
|
|
|
|
|
|
|
|
|
| P1148A in fibrillin-1 is not a mutation leading to Shprintzen-Goldberg syndrome |
|
|
|
|
|
|
|
|
|
| Analysis of multiple mitochondrial DNA deletions in inclusion body myositis |
|
|
|
|
|
|
|
|
|
| Novel point mutation within intron 10 ofFMR-1 gene causing fragile X syndrome |
|
|
|
|
|
|
|
|
|
| SSCP analysis of long DNA fragments in low pH gel |
|
|
|
|
|
|
|
|
|
| Strategy for identification of sequence variants in COL7A1 and a novel 2-bp deletion mutation in recessive dystrophic epidermolysis bullosa |
|
|
|
|
|
|
|
|
|
| Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16 |
|
|
|
|
|
|
|
|
|
| A glycine (415)-to-serine substitution results in impaired secretion and decreased thermal stability of type III procollagen in a patient with Ehlers-Danlos syndrome type IV |
|
|
|
|
|
|
|
|
|
| Probable identity by descent and discovery of familial relationships by means of a rare β-thalassemia haplotype |
|
|
|
|
|
|
|
|
|
| Mutations in the N-terminal globular domain of the type X collagen gene (COL10A1) in patients with Schmid metaphyseal chondrodysplasia |
|
|
|
|
|
|
|
|
|
| Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in theCFTR gene |
|
|
|
|
|
|
|
|
|
| Introduction of a
<i>myc</i>
reporter tag to improve the quality of mutation detection using the protein truncation test |
|
|
|
|
|
|
|
|
|
| Three novel
<i>PAX3</i>
mutations observed in patients with Waardenburg syndrome type 1 |
|
|
|
|
|
|
|
|
|
| Screening and biochemical characterization of transthyretin variants in the Portuguese population |
|
|
|
|
|
|
|
|
|
| Frequency of RET mutations in long- and short-segment Hirschsprung disease |
|
|
|
|
|
|
|
|
|
| Relative frequency of IVS10nt546 mutation in a Portuguese phenylketonuric population |
|
|
|
|
|
|
|
|
|
| Germline versus somatic mutations of theAPC gene: Evidence for mechanistic differences |
|
|
|
|
|
|
|
|
|
| Screening of 229 family cancer patients for a germline estrogen receptor gene (ESR) base mutation |
|
|
|
|
|
|
|
|
|
| Prediction of multiple hypermutable codons in the human PAH gene: Codon 280 contains recurrent mutations in Quebec and other populations |
|
|
|
|
|
|
|
|
|
| Mutations in theXPD gene leading to xeroderma pigmentosum symptoms |
|
|
|
|
|
|
|
|
|
| Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene |
|
|
|
|
|
|
|
|
|
| Identification of four novel mutations in the cystic fibrosis transmembrane conductance regulator gene: E664X, 2113delA, 306delTAGA, and ΔM1140 |
|
|
|
|
|
|
|
|
|
| Characterization of 19 novel and six recurring APC mutations in Italian adenomatous polyposis patients, using two different mutation detection techniques |
|
|
|
|
|
|
✓ |
|
Italian |
| Identification of novel missense mutations in the Norrie disease gene associated with one X-linked and four sporadic cases of Familial Exudative Vitreoretinopathy |
|
|
|
|
|
|
|
|
|
| Ornithine transcarbamylase deficiency: Ten new mutations and high proportion of de novo mutations in heterozygous females |
|
|
|
|
|
|
|
|
|
| Tissue distribution of the ND4/11778 mutation in heteroplasmic lineages with Leber hereditary optic neuropathy |
|
|
|
|
|
|
|
|
|
| (G586V) substitutions in the α1 and α2 chains of collagen I: Effect of α-chain stoichiometry on the phenotype of osteogenesis imperfecta? |
|
|
|
|
|
|
|
|
|
| A new missense mutation in exon 6 of the proteolipid protein gene in a patient with Pelizaeus‐Merzbacher disease |
|
|
|
|
|
|
|
|
|
| Large majority of single-nucleotide mutations along the dystrophin gene can be explained by more than one mechanism of mutagenesis |
|
|
|
|
|
|
|
|
|
| NF1 mutation analysis using a combined heteroduplex/SSCP approach |
|
|
|
|
|
|
|
|
|
| Identification of two novel LDL receptor gene defects in French-Canadian pediatric population: Mutational analysis and biochemical studies |
|
|
|
|
|
|
|
|
|
| Facilitated diagnosis of CMT1A duplication in chromosome 17p11.2-12: Analysis with a CMT1A-REP repeat probe and photostimulated luminescence imaging |
|
|
|
|
|
|
|
|
|
| Analysis of multiple mitochondrial DNA deletions in inclusion body myositis |
|
|
|
|
|
|
|
|
|
| Adult vitelliform macular dystrophy is frequently associated with mutations in the peripherin/RDS gene |
|
|
|
|
|
|
|
|
|
| SSCP analysis of long DNA fragments in low pH gel |
|
|
|
|
|
|
|
|
|
| Quantitative enriched PCR (QEPCR), a highly sensitive method for detection of K-ras oncogene mutation |
|
|
|
|
|
|
|
|
|
| Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X‐linked agammaglobulinemia |
|
|
|
|
|
|
|
|
|
| Analysis of 22 cystic fibrosis mutations in 62 patients from the Flanders, Belgium, reveals a high prevalence of Nordic mutation 394delTT |
|
|
|
|
|
|
✓ |
|
Nordic |
| Fibrillin‐1 mutations in Marfan syndrome and other type‐1 fibrillinopathies |
|
|
|
|
|
|
|
|
|
| Mutation analysis of the connexin 32 (Cx32) gene in charcot‐marie‐tooth neuropathy type 1: Identification of five new mutations |
|
|
|
|
|
|
|
|
|
| Three novel mutations in the coproporphyrinogen oxidase gene |
|
|
|
|
|
|
|
|
|
| Mutations and DNA diagnoses of classical citrullinemia |
|
|
|
|
|
|
|
|
|
| Novel HEXA mutation in a Bedouin Tay‐Sachs patient associated with exon skipping and reduced transcript level |
|
|
|
|
|
|
✓ |
|
Bedouin |
| Identification of three novel frameshift mutations (83delAT, 754insCT, and 435 + 1G to A) of mitochondrial acetoacetyl‐coenzyme A thiolase gene in two Swiss patients with CRM‐negative β‐ketothiolase d |
|
|
|
|
|
|
|
|
|
| Germline versus somatic mutations of the APC gene: Evidence for mechanistic differences |
|
|
|
|
|
|
|
|
|
| Screening of 229 family cancer patients for a germline estrogen receptor gene (ESR) base mutation |
|
|
|
|
|
|
|
|
|
| Mutations in the XPD gene leading to xeroderma pigmentosum symptoms |
|
|
|
|
|
|
|
|
|
| Novel and recurrent mutations in the neurofibromatosis type 1 (NF1) gene |
|
|
|
|
|
|
|
|
|
| Characterization of 19 novel and six recurring APC mutations in Italian adenomatous polyposis patients, using two different mutation detection techniques |
|
|
|
|
|
|
|
|
|
| Similar mutant frequencies observed between pairs of monozygotic twins |
|
|
|
|
|
|
|
|
|
| Deletions spanning the neurofibromatosis type 1 gene: Implications for genotype‐phenotype correlations in neurofibromatosis type 1? |
|
|
|
|
|
|
|
|
|
| Scanning method of identify the molecular heterogeneity of δ‐globin gene especially in δ‐thalassemias: Detection of three novel substitutions in the promoter region of the gene |
|
|
|
|
|
|
|
|
|
| New nonsense mutation in the breast cancer‐1 gene in a French site‐specific breast cancer family |
|
|
|
|
|
|
|
|
|
| Simultaneous genotyping for all three known structural mutations in the human mannose‐binding lectin gene |
|
|
|
|
|
|
|
|
|
| Identification of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency in four Italian families |
|
|
|
|
|
|
|
|
|
| Mutations in the adrenoleukodystrophy gene |
|
|
|
|
|
|
|
|
|
| Molecular basis of HNPCC: Mutations of MMR genes |
|
|
|
|
|
|
|
|
|
| Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene |
|
|
|
|
|
|
|
|
|
| Mutations of the RET proto‐oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease |
|
|
|
|
|
|
|
|
|
| Multiple de novo MPZ (P0) point mutations in a sporadic Dejerine‐Sottas case |
|
|
|
|
|
|
|
|
|
| Identification of a one‐base germline deletion (codon 888 del C) and an intron splice acceptor site polymorphism in hMSH2 |
|
|
|
|
|
|
|
|
|
| Homozygosity for the common Ashkenazi Jewish Tay‐Sachs +1 IVS‐12 splice‐junction mutation: First report |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jewish |
| Diversity of ATM gene mutations detected in patients with ataxia‐telangiectasia |
|
|
|
|
|
|
|
|
|
| Cys 618 Arg mutation in the RET proto‐oncogene associated with familial medullary thyroid carcinoma and maternally transmitted Hirschsprung's disease suggesting a role for imprinting |
|
|
|
|
|
|
|
|
|
| G6PD Sumaré: A novel mutation in the G6PD gene (1292 T→G) associated with chronic nonspherocytic anemia |
|
|
|
|
|
|
|
|
|
| Molecular genetics of Krabbe disease (globoid cell leukodystrophy): Diagnostic and clinical implications |
|
|
|
|
|
|
|
|
|
| Tay‐Sachs disease and HEXA mutations among Moroccan Jews |
|
|
|
|
|
|
✓ |
|
Moroccan Jews |
| Molecular basis of dystrophic epidermolysis bullosa: Mutations in the type VII collagen gene (COL7A1) |
|
|
|
|
|
|
|
|
|
| Glucocerebrosidase genotype of Gaucher patients in The Netherlands: Limitations in prognostic value |
|
|
|
|
|
|
|
|
|
| Novel point mutation within intron 10 of FMR1 gene causing fragile X syndrome |
|
|
|
|
|
|
|
|
|
| Two mutated HEXA alleles in a Druze patient with late‐infantile Tay‐Sachs disease |
|
|
|
|
|
|
✓ |
|
Druze |
| Analysis of (CAG)n size heterogeneity in somatic and sperm cell DNA from intermediate and expanded Huntington disease gene carriers |
|
|
|
|
|
|
|
|
|
| A glycine (415)‐to‐serine substitution results in impaired secretion and decreased thermal stability of type III procollagen in a patient with Ehlers‐Danlos syndrome type IV |
|
|
|
|
|
|
|
|
|
| A novel splice site mutation (156 + 1G→A) in the TSC2 gene |
|
|
|
|
|
|
|
|
|
| A novel missense point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patient with familal motor neuron disease |
|
|
|
|
|
|
|
|
|
| Two new recurrent nucleotide mutations in the COL1A1 gene in four patients with osteogenesis imperfecta: About one‐fifth are recurrent |
|
|
|
|
|
|
|
|
|
| Startle disease in an Italian family by mutation (K276E): The α‐subunit of the inhibiting glycine receptor |
|
|
|
|
|
|
|
|
|
| Novel mutations and polymorphisms in the human dystrophin gene detected by double‐strand conformation analysis |
|
|
|
|
|
|
|
|
|
| Three novel germline mutations in the adenomatous polyposis coli gene |
|
|
|
|
|
|
|
|
|
| Metachromatic leukodystrophy: Identification of the first deletion in exon 1 and nine novel point mutations in the arylsulfatase A gene |
|
|
|
|
|
|
|
|
|
| Single‐step DGGE‐based mutation scanning of the p53 gene: Application to genetic diagnosis of colorectal cancer |
|
|
|
|
|
|
|
|
|
| Tissue distribution of the ND4/11778 mutation in heteroplasmic lineages with Leber hereditary optic neuropathy |
|
|
|
|
|
|
|
|
|
| Analysis of the myoglobin gene in heart disease |
|
|
|
|
|
|
|
|
|
| Identification of a novel somatic mutation in the RET proto‐oncogene in a patient with sporadic medullary thyroid carcinoma |
|
|
|
|
|
|
|
|
|
| Large majority of single‐nucleotide mutations along the dystrophin gene can be explained by more than one mechanism of mutagenesis |
|
|
|
|
|
|
|
|
|
| Facilitated diagnosis of CMT1A duplication in chromosome 17p11.2‐12: Analysis with a CMT1A‐REP repeat probe and photostimulated luminescence imaging |
|
|
|
|
|
|
|
|
|
| Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations |
|
|
|
|
|
|
|
|
|
| Identification of novel missense mutations in the Norrie disease gene associated with one X‐linked and four sporadic cases of Familial Exudative Vitreoretinopathy |
|
|
|
|
|
|
|
|
|
| Mutations associated with hemophilia B in Turkish patients |
|
|
|
|
|
|
|
|
|
| Familial ligand‐defective apolipoprotein B‐100: Simultaneous detection of the ARG3500→GLN and ARG3531→CYS mutations in a French population |
|
|
|
|
|
|
✓ |
|
French population |
| Identification of a new mutation of the myosin VII head region in Usher syndrome type 1 |
|
|
|
|
|
|
|
|
|
| Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1) |
|
|
|
|
|
|
|
|
|
| Hereditary coproporphyria: Exon screening by heteroduplex analysis detects three novel mutations in the coproporphyrinogen oxidase gene |
|
|
|
|
|
|
|
|
|
| Constitutive APC exon 14 skipping in early‐onset familial adenomatous polyposis reveals a dramatic quantitative distortion of APC gene‐specific isoforms |
|
|
|
|
|
|
|
|
|
| Mutation screening of all 65 exons of the fibrillin‐1 gene in 60 patients with Marfan syndrome: Report of 12 novel mutations |
|
|
|
|
|
|
|
|
|
| APC mutations in familial adenomatous polyposis families in the Northwest of England |
|
|
|
|
|
|
|
|
|
| Missense mutation R1066C in the second transmembrane domain of CFTR causes a severe cystic fibrosis phenotype: Study of 19 heterozygous and 2 homozygous patients |
|
|
|
|
|
|
|
|
|
| Molecular basis of heat labile hexosaminidase B among Jews and Arabs |
|
|
|
|
|
|
✓ |
|
Jews and Arabs |
| Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas |
|
|
|
|
|
|
|
|
|
| Mutations in mut methylmalonic acidemia: Clinical and enzymatic correlations |
|
|
|
|
|
|
|
|
|
| New splicing mutation in exon 5–6 of the p53‐tumor suppressor gene in a malignant schwannoma |
|
|
|
|
|
|
|
|
|
| Mutations in the N‐terminal globular domain of the type X collagen gene (COL10A1) in patients with Schmid metaphyseal chondrodysplasia |
|
|
|
|
|
|
|
|
|
| Three novel PAX3 mutations observed in patients with Waardenburg syndrome type 1 |
|
|
|
|
|
|
|
|
|
| Mutations in fibrillar collagens (types I, II, III, and XI), fibril‐associated collagen (type IX), and network‐forming collagen (type X) cause a spectrum of diseases of bone, cartilage, and blood vess |
|
|
|
|
|
|
|
|
|
| Identification of a splice site mutation (2789+5 G>A) associated with small amounts of normal CFTRmRNA and mild cystic fibrosis |
|
|
|
|
|
|
|
|
|
| δ‐Thalassemic phenotype due to two “novel” δ‐globin gene mutations: CD11[GTC → GGC (A8)‐HbA2‐pylos] and CD 85 [TTT → TCT (F1)‐HbA2‐etolia] |
|
|
|
|
|
|
|
|
|
| Norrie disease gene mutation in a large Costa Rican kindred with a novel phenotype including venous insufficiency |
|
|
|
|
|
|
|
|
|
| (G586V) substitutions in the α1 and α2 chains of collagen I: Effect of α‐chain stoichiometry on the phenotype of osteogenesis imperfecta? |
|
|
|
|
|
|
|
|
|
| Two mutations in the same low‐density lipoprotein receptor allele act in synergy to reduce receptor function in heterozygous familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Nine novel L1 CAM mutations in families with X‐linked hydrocephalus |
|
|
|
|
|
|
|
|
|
| DNA repair characteristics and mutations in the ERCC2 DNA repair and transcription gene in a trichothiodystrophy patient |
|
|
|
|
|
|
|
|
|
| An efficient and reliable multiplex PCR‐SSCP mutation analysis test applied to the human E‐cadherin gene |
|
|
|
|
|
|
|
|
|
| The clinical spectrum of type IV collagen mutations |
|
|
|
|
|
|
|
|
|
| Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: Association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmon |
|
|
|
|
|
|
|
|
|
| SSCP analysis: A blind sensitivity trial |
|
|
|
|
|
|
|
|
|
| The cystic fibrosis ΔF508 gene mutation and cancer |
|
|
|
|
|
|
|
|
|
| An expanded histatin gene polymorphism and test of a possible disease resistant phenotype |
|
|
|
|
|
|
|
|
|
| Mucopolysaccharidosis type II: Identification of six novel mutations in Italian patients |
|
|
|
|
|
|
|
|
|
| 24 bp deletion and Ala1278 to val mutation of the ATP7B gene in a Sardinian family with Wilson disease |
|
|
|
|
|
|
|
|
|
| Novel mutation (A141D) in exon 4 of the CFTR gene identified in an Algerian patient |
|
|
|
|
|
|
|
|
|
| Six novel mutations in the neurofibromatosis type 1 (NF1) gene |
|
|
|
|
|
|
|
|
|
| Registries of immunodeficiency patients and mutations |
|
|
|
|
|
|
|
|
|
| P1148A in fibrillin‐1 is not a mutation leading to Shprintzen‐Goldberg syndrome |
|
|
|
|
|
|
|
|
|
| Identification of 16 sulfamidase gene mutations including the common R74C in patients with mucopolysaccharidosis type IIIA (Sanfilippo A) |
|
|
|
|
|
|
|
|
|
| Method for in situ investigation of mitochondrial DNA deletions |
|
|
|
|
|
|
|
|
|
| An improved methodology for the detection of the common mutation in the FGFR3 gene responsible for achondroplasia |
|
|
|
|
|
|
|
|
|
| Two extremes of the clinical spectrum of glycogen storage disease type II in one family: A matter of genotype |
|
|
|
|
|
|
|
|
|
| Mutations and polymorphisms in the tuberous sclerosis complex gene on chromosome 16 |
|
|
|
|
|
|
|
|
|
| A nonsense mutation due to a single base insertion in the 3′‐coding region of glycogen debranching enzyme gene associated with a severe phenotype in a patient with glycogen storage disease type IIIa |
|
|
|
|
|
|
|
|
|
| Two new mutations in exon 3 of the NDP gene: S73X and S101F associated with severe and less severe ocular phenotype, respectively |
|
|
|
|
|
|
|
|
|
| Phenylketonuria in Spanish Gypsies: Prevalence of the IVS10nt546 mutation on haplotype 34 |
|
|
|
|
|
|
✓ |
|
Spanish Gypsies |
| Two novel mutations (K384E and L539S) in the C‐terminal moiety of the cystathionine β‐synthase protein in two French pyridoxine‐responsive homocystinuria patients |
|
|
|
|
|
|
✓ |
|
French |
| Transthyretin ILE20, a new variant associated with late‐onset cardiac amyloidosis |
|
|
|
|
|
|
|
|
|
| Probable identity by descent and discovery of familial relationships by means of a rare β‐thalassemia haplotype |
|
|
|
|
|
|
|
|
|
| Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis |
|
|
|
|
|
|
|
|
|
| Identification of two mutations (S50Y and 4173delC) in the CFTR gene from patients with congenital bilateral absence of vas deferens (CBAVD) |
|
|
|
|
|
|
|
|
|
| Tay‐Sachs disease‐causing mutations and neutral polymorphisms in the Hex A gene |
|
|
|
|
|
|
|
|
|
| A five‐basepair deletion (7118 delTTTTA) identified within neurofibromatosis NF1 exon 39 |
|
|
|
|
|
|
|
|
|
| NF1 mutation analysis using a combined heteroduplex/SSCP approach |
|
|
|
|
|
|
|
|
|
| Glycogenosis type II: A juvenile‐specific mutation with an unusual splicing pattern and a shared mutation in African Americans |
|
|
|
|
|
|
✓ |
|
African Americans |
| A single Ser259Arg mutation in the gene for lipoprotein lipase causes chylomicronemia in Moroccans of Berber ancestry |
|
|
|
|
|
|
✓ |
|
Moroccans of Berber ancestry |
| Identification of 31 novel mutations in the N‐acetylgalactosamine‐6‐sulfatase gene reveals excessive allelic heterogeneity among patients with Morquio A syndrome |
|
|
|
|
|
|
|
|
|
| Molecular basis of choroideremia (CHM): Mutations involving the rab escort protein‐1 (REP1) gene |
|
|
|
|
|
|
|
|
|
| Familial lipoprotein lipase (LPL) deficiency: A catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy |
|
|
|
|
|
|
|
|
|
| Screening and biochemical characterization of transthyretin variants in the Portuguese population |
|
|
|
|
|
|
|
|
|
| Fourteen novel mucopolysaccharidosis IVA producing mutations in GALNS gene |
|
|
|
|
|
|
|
|
|
| Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia |
|
|
|
|
|
|
|
|
|
| Strategy for identification of sequence variants in COL7A1 and a novel 2‐bp deletion mutation in recessive dystrophic epidermolysis bullosa |
|
|
|
|
|
|
|
|
|
| Seven novel mutations in carbonic anhydrase II deficiency syndrome identified by SSCP and direct sequencing analysis |
|
|
|
|
|
|
|
|
|
| Molecular heterogeneity of classical and duarte galactosemia: Mutation analysis by denaturing gradient gel electrophoresis |
|
|
|
|
|
|
|
|
|
| Novel point mutations in the dystrophin gene |
|
|
|
|
|
|
|
|
|
| Two novel frameshift deletions (1924del7, 2055del9→A) in the CFTR gene in Mexican cystic fibrosis patients |
|
|
|
|
|
|
|
|
|
| Human APRT deficiency: Indication for multiple origins of the most common Caucasian mutation and detection of a novel type of mutation involving intrastrand‐templated repair |
✓ |
|
|
|
|
|
|
|
|
| Hunter disease in a girl caused by R468Q mutation in the iduronate‐2‐sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele |
|
|
|
|
|
|
|
|
|
| The repeat expansion detection method in the analysis of diseases with CAG/CTG repeat expansion: Usefulness and limitations |
|
|
|
|
|
|
|
|
|
| Relative frequency of IVS10nt546 mutation in a Portuguese phenylketonuric population |
|
|
|
|
|
|
|
|
|
| Mutations in the GTP cyclohydrolase I and 6‐pyruvoyl‐tetrahydropterin synthase genes |
|
|
|
|
|
|
|
|
|
| Six novel mutations in the emerin gene causing X‐linked Emery‐Dreifuss muscular dystrophy |
|
|
|
|
|
|
|
|
|
| Charcot‐Marie‐Tooth disease with intermediate motor nerve conduction velocities: Characterization of 14 C×32 mutations in 35 families |
|
|
|
|
|
|
|
|
|
| Oligonucleotide micro‐arrays for identification of unknown mutations: how far from reality? |
|
|
|
|
|
|
|
|
|
| Novel mutations of the P gene in type II oculocutaneous albinism (OCA2) |
|
|
|
|
|
|
|
|
|
| The molecular basis of X‐linked deafness type 3 (DFN3) in two sporadic cases: Identification of a somatic mosaicism for a POU3F4 missense mutation |
|
|
|
|
|
|
|
|
|
| A novel mutation (L174R) in the Ca2‐sensing receptor gene associated with familial hypocalciuric hypercalcemia |
|
|
|
|
|
|
|
|
|
| Lipoamide dehydrogenase deficiency in Ashkenazi Jews: An insertion mutation in the mitochondrial leader sequence |
|
|
|
|
|
|
✓ |
|
Ashkenazi Jews |
| Mutations of the phenylalanine hydroxylase gene in mild hyperphenylalaninemia: A novel mutation in exon 3 |
|
|
|
|
|
|
|
|
|
| Evidence for founder effect of the glu104asp substitution and identification of new mutations in triosephosphate isomerase deficiency |
|
|
|
|
|
|
|
|
|
| Confirmation of homozygosity for a single nucleotide substitution mutation in a Cockayne syndrome patient using monoallelic mutation analysis in somatic cell hybrids |
|
|
|
|
|
|
|
|
|
| Imprinting mutations on human chromosome 15 |
|
|
|
|
|
|
|
|
|
| Cystic fibrosis mutation frequencies in upstate New York |
|
|
|
|
|
|
|
|
|
| Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects |
|
|
|
|
|
|
|
|
|
| Mutations of the androgen receptor gene in patients with complete androgen insensitivity |
|
|
|
|
|
|
|
|
|
| Novel missense mutation in the coagulation factor IX catalytic domain associated with moderate disease |
|
|
|
|
|
|
|
|
|
| Molecular analysis of the APC gene in 105 Dutch kindreds with familial adenomatous polyposis: 67 germline mutations identified by DGGE, PTT, and southern analysis |
|
|
|
|
|
|
|
|
|
| Phenylketonuria splice mutation (EXON6nt‐96Ag) masquerading as missense mutation (Y204C) |
|
|
|
|
|
|
|
|
|
| Introduction of a myc reporter tag to improve the quality of mutation detection using the protein truncation test |
|
|
|
|
|
|
|
|
|
| E380D: A novel point mutation of CYP21 in an HLA‐homozygous patient with salt‐losing congenital adrenal hyperplasia due to 21‐hydroxylase deficiency |
|
|
|
|
|
|
|
|
|
| A clinical overview of WT1 gene mutations |
|
|
|
|
|
|
|
|
|
| A high incidence of mutations in exon 6 of the low‐density lipoprotein receptor gene in Greek familial hypercholesterolemia patients, including a novel mutation |
|
|
|
|
|
|
|
|
|
| Complex trinucleotide repeat polymorphism in the HOX B6 gene |
|
|
|
|
|
|
|
|
|
| G→T transition at cDNA nt 110 (K37Q) in the PKLR (pyruvate kinase) gene is the molecular basis of a case of hereditary increase of red blood cell ATP |
|
|
|
|
|
|
|
|
|
| Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: Overview |
|
|
|
|
|
|
|
|
|
| Prediction of multiple hypermutable codons in the human PAH gene: Codon 280 contains recurrent mutations in Quebec and other populations |
|
|
|
|
|
|
|
|
|
| Novel nonsense mutation (W302X) in the steroid 21‐hydroxylase gene of a Finnish patient with the salt‐wasting form of congenital adrenal hyperplasia |
|
|
|
|
|
|
✓ |
|
Finnish |
| Identification of four novel mutations in the cystic fibrosis transmembrane conductance regulator gene: E664X, 2113delA, 306delTAGA, and ΔM1140 |
|
|
|
|
|
|
|
|
|
| Ornithine transcarbamylase deficiency: Ten new mutations and high proportion of de novo mutations in heterozygous females |
|
|
|
|
|
|
|
|
|
| Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion |
|
|
|
|
|
|
|
|
|
| Recurrent COL3A1 mutation results in EDS IV or familial aneurysms |
|
|
|
|
|
|
|
|
|
| A new missense mutation in exon 6 of the proteolipid protein gene in a patient with Pelizaeus‐Merzbacher disease |
|
|
|
|
|
|
|
|
|
| Three novel mutations of the PKD1 gene in Italian families with autosomal dominant polycystic kidney disease |
|
|
|
|
|
|
|
|
|
| Characterization of a deletion mutation involving exons 3–7 of the WASP gene detected in a patient with Wiskott‐Aldrich syndrome |
|
|
|
|
|
|
|
|
|
| Identification of two novel LDL receptor gene defects in French‐Canadian pediatric population: Mutational analysis and biochemical studies |
|
|
|
|
|
|
✓ |
|
French-Canadian |
| Common founder mutation in the LDL receptor gene causing familial hypercholesterolaemia in the Icelandic population |
|
|
|
|
|
|
|
|
|
| Sporadic heteroplasmic single 5.5 Kb mitochondrial DNA deletion associated with cerebellar ataxia, hypogonadotropic hypogonadism, choroidal dystrophy, and mitochondrial respiratory chain complex I def |
|
|
|
|
|
|
|
|
|
| Hereditary nonpolyposis colorectal cancer (HNPCC): Eight novel germline mutations in hMSH2 or hMLH1 genes |
|
|
|
|
|
|
|
|
|
| Two novel (1334delC and 1363G to A, G455R) mutations in exon 12 of the β‐hexosaminidase α‐chain gene in two Portuguese patients |
|
|
|
|
|
|
|
|
|
| Analysis of mutations and chromosomal localisation of the gene encoding RFX5, a novel transcription factor affected in major histocompatibility complex class II deficiency |
|
|
|
|
|
|
|
|
|
| Novel mutation of the myelin P0 gene in a CMT1B family |
|
|
|
|
|
|
|
|
|
| CTG trinucleotide repeat lengths in myotonic dystrophy alleles of patients with senile cataracts |
|
|
|
|
|
|
|
|
|
| Three germline mutations in the TP53 gene |
|
|
|
|
|
|
|
|
|
| Mutational analysis of the hMLH1 gene using an automated two‐dimensional DNA typing system |
|
|
|
|
|
|
|
|
|
| Quantitative allele‐specific PCR: Demonstration of age‐associated accumulation in human tissues of the A→G mutation at nucleotide 3243 in mitochondrial DNA |
|
|
|
|
|
|
|
|
|
| Detection of mutations in multi‐exon genes: Comparison of conformation sensitive gel electrophoresis and sequencing strategies with respect to cost and time for finding mutations |
|
|
|
|
|
|
|
|
|
| Novel G16S (GGC‐AGC) mutation in the SOD1 gene in a patient with apparently sporadic young‐onset amyotrophic lateral sclerosis |
|
|
|
|
|
|
|
|
|
| Three novel fibrillin mutations in exons 25 and 27: Classic versus neonatal Marfan syndrome |
|
|
|
|
|
|
|
|
|
| New evidence for a mutation hotspot in exon 37 of the NF1 gene |
|
|
|
|
|
|
|
|
|
| Serine for glycine substitutions in the C‐terminal third of the α1(I) chain of collagen I in five patients with nonlethal osteogenesis imperfecta |
|
|
|
|
|
|
|
|
|
| Three novel point mutations in the dystrophin gene in DMD patients |
|
|
|
|
|
|
|
|
|
| Frequency of RET mutations in long‐ and short‐segment Hirschsprung disease |
|
|
|
|
|
|
|
|
|
| Mutations in purine nucleoside phosphorylase deficiency |
|
|
|
|
|
|
|
|
|
| E280A PS‐1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles |
|
|
|
|
|
|
|
|
|
| Screening for ESR mutations in breast and ovarian cancer patients |
|
|
|
|
|
|
|
|
|
| Mutations in SRY and SOX9: Testis‐determining genes |
|
|
|
|
|
|
|
|
|